Mizuho Securities analyst Ann Hynes maintained a Buy rating on CVS Health Corp (NYSE:CVS) on Tuesday, setting a price target of $98, which is approximately 16.86% above the present share price of $83.86.
Hynes expects CVS Health Corp to post earnings per share (EPS) of $2.11 for the third quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Strong Buy rating of shares in CVS Health, with an average price target of $100.27.
The analysts price targets range from a high of $114 to a low of $83.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $72.62 billion and a net profit of $4.33 billion. The company's market cap is $110.66 billion.
According to TipRanks.com, Mizuho Securities analyst Ann Hynes is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 12.8% and a 64.26% success rate.
Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna (NYSE:AET), a health insurance provider, among many other brands.